Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ponatinib in cHronic myelOid LEukemia patieNts In Chronic phaSe: the PHOENICS Protocol

NCT06119269 is registered in ClinicalTrials.gov with University of Pisa as lead sponsor.

NCT NCT06119269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06119269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ponatinib in cHronic myelOid LEukemia patieNts In Chronic phaSe: the PHOENICS Protocol
Lead sponsor
University of Pisa
Phase
Observational
Overall status
Recruiting
Start date
August 2, 2023
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, chronic phase